arrow
P

Paul K. Drain

university of washington seattle
H指数:27
被引数:2,436

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring: qualitative findings from a randomized controlled trial in South Africa

对基于诊所的尿液替诺福韦检测用于抗逆转录病毒疗法依从性监测的接受度和前景:来自南非一项随机对照试验的定性研究结果

2026-05-010
PRE
Oral Fluid Concentrations of Tenofovir and Emtricitabine for Monitoring HIV Antiretroviral Adherence: Findings From a Randomized Trial with Directly Observed Therapy (TARGET Study)

唾液中替诺福韦和恩曲他滨的浓度用于监测HIV抗逆转录病毒治疗依从性:直接观察治疗随机试验(TARGET研究)的结果

2026-01-010
OAAI
Disease priorities and rapid diagnostics testing preferences among community members in KwaZulu-Natal, South Africa: a formative qualitative study

南非夸祖鲁-纳塔尔省社区居民的疾病优先级与快速诊断测试偏好:一项形成性定性研究

2025-11-180
OA
HIV Resistance to Dolutegravir Varies With Coadministered Agents

Beck, I.A.; Boyce, C.L.; Bishop, M.D.; Oldroyd, A.R.; du Toit, L.; Saimen, A.; Ramarope, K.M.; Hitchcock, S.; du Plessis, N.M.; Mbogo, L.; et al. HIV对多替拉韦的抗药性因联合用药剂而异。临床传染病杂志. 2025; 已接收待发表。 [Google Scholar] [CrossRef]

2025-09-020
PRE
Critical lessons from a pragmatic randomized trial of home-based COVID-19 testing in rural Native American and Latino communities

在美国农村原住民和拉丁裔社区进行基于家庭的新型冠状病毒肺炎测试的实用随机试验的重要经验

2024-03-061
OA
Rapid Antigen and Antibody Microfluidic Immunofluorescence Assays Compared to Culture, PCR, and Laboratory Reference Tests: Performance in a Longitudinal Cohort

与培养,PCR和实验室参考测试相比,快速抗原和抗体微流体免疫荧光测定: 纵向队列中的性能

2023-06-240
PRE
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis

世卫组织推荐的筛查工具的临床实用性以及开发和验证用于门诊HIV感染者中肺结核筛查的新型临床预测模型: 个体参与者数据荟萃分析

2023-06-071
OAAI
Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study
2023-04-018
OAAI
Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron

SARS-CoV-2 VOC中和的动力学和新型mAb揭示了对Omicron的保护

2023-02-143
OAAI